Related Experiment Video
Updated: Jan 18, 2026

11:22
Engineering Biological-Based Vascular Grafts Using a Pulsatile Bioreactor
Published on: June 14, 2011
17.6K
Optimized biomechanical design of a tissue engineered pulsatile Fontan conduit
Nir Emuna1, Zinan Hu2, Alison L Marsden2
1Department of Biomedical Engineering Yale University, New Haven, CT, USA. nir.emuna@gmail.com.
NPJ Regenerative Medicine
|January 15, 2026
Summary
This study introduces a novel biomechanical framework for designing pulsatile conduits to restore heart function in children with congenital heart defects, aiming to improve circulation and lifespan.
Area of Science:
- Biomedical Engineering
- Regenerative Medicine
- Pediatric Cardiology
Background:
- Congenital heart defects (CHDs) survivors face lifelong challenges due to non-physiological Fontan circulation.
- Current surgical palliation for CHDs leads to significant sequelae and reduced lifespan.
- Restoring subpulmonic pumping function is a critical unmet need in pediatric cardiac surgery.
Purpose of the Study:
- To develop an analytically based framework for designing pulsatile conduits using biomechanical principles.
- To optimize conduit performance for pediatric anatomical constraints.
- To demonstrate the clinical potential of a novel pulsatile conduit design.
Main Methods:
- Coupling passive matrix architecture and properties with embedded myofibers.
- Parametric exploration of matrix properties and myofiber orientations.
- Utilizing patient-specific hemodynamic models for performance evaluation.
Main Results:
- Biomechanically feasible pulsatile conduit designs were identified.
- Sensitivity analyses confirmed design robustness and identified critical parameters for biomanufacturing and surgery.
- An optimized pulsatile conduit demonstrated the potential to generate physiologically meaningful pressures and flows, outperforming passive grafts.
Conclusions:
- The developed framework provides a rigorous biomechanical basis for designing functional pulsatile conduits.
- This approach holds promise for improving outcomes in pediatric patients with CHDs.
- Optimized pulsatile conduits represent a significant advancement over current passive grafts for Fontan circulation.

